PREPARATION OF [I-131] LIPIODOL AS A HEPATOMA THERAPEUTIC AGENT

被引：0
|
作者：
LO, JG
WANG, AY
WEI, YY
LUI, WY
CHI, CW
CHAN, WK
机构：
[1] TAIPEI VET GEN HOSP,TAIPEI,TAIWAN
[2] ACAD SINICA,INST BIOMED SCI,TAIPEI 115,TAIWAN
来源：
APPLIED RADIATION AND ISOTOPES | 1992年 / 43卷 / 12期
关键词：
D O I：
暂无
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
An isotopic exchange method was used to label lipiodol with I-131. The labelling efficiency was > 92.5%, and the radiochemical purity of [I-131]lipiodol was above 98% as determined by ITLC. The influencing factors e.g. the beating temperature, reaction time, pH and storage conditions were studied and the optimum conditions were determined. In a pilot study injecting [I-131]lipiodol for the treatment of hepatoma, about 70% of hepatoma patients had a response to the treatment with a reduction of alpha-fetoprotein and decrease of hepatoma sizes. The overall median survival was 9 months (range 2-17 months).
引用
收藏
页码：1431 / 1435
页数：5
相关论文
共 50 条
  • [31] Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma
    Maini, CL
    Scelsa, MG
    Tofani, A
    Sciuto, R
    Tipaldi, L
    DAnnibale, M
    Santoro, E
    CLINICAL NUCLEAR MEDICINE, 1996, 21 (03) : 221 - 226
  • [32] 74 MBq radioiodine I-131 does prevent uptake of therapeutic activity of I-131 in residual thyroid tissue
    Medvedec, M
    Pavlinovic, Z
    Dodig, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1013 - 1013
  • [33] LOCALIZATION OF I-131 IN BIOSYNTHETICALLY LABELLED [I-131]THYROXINE
    PLASKETT, LG
    BIOCHEMICAL JOURNAL, 1959, 73 : 115 - 119
  • [34] Determination of Radiochemical and Radionuclide Purity of a I-131 Preparation
    Tselishchev, I. V.
    Savochkin, Yu. P.
    Mel'nik, M. I.
    Trepalina, T. F.
    RADIOCHEMISTRY, 2007, 49 (02) : 178 - 181
  • [35] PREPARATION OF [I-131] IODINATED NONOXYNOL-9
    AGHA, BJ
    GARBOLAS, GA
    WETS, K
    DIGENIS, GA
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1984, 21 (09): : 821 - 831
  • [36] PREPARATION OF IODINE SOURCE IN I-131 LABELED CRYSTALS
    ARGIERO, L
    BANDITEL.P
    LANZA, S
    CHIMICA & L INDUSTRIA, 1971, 53 (11): : 1039 - &
  • [37] Preparation and Analysis of 4-Iodoantipyrine-(I-131)
    DiMattio, Joseph
    Hochwald, G. M.
    STROKE, 1972, 3 (04) : 446 - 448
  • [38] HYPERTHYROIDISM, ANTITHYROID DRUG PREPARATION, AND I-131 THERAPY
    NUSYNOWITZ, ML
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (13): : 1761 - 1762
  • [39] THE MEASUREMENT OF TRACER I-132 IN THE PRESENCE OF THERAPEUTIC I-131
    ORVIS, AL
    DUNNETTE, WH
    COLBY, MY
    RADIATION RESEARCH, 1956, 5 (05) : 589 - 589
  • [40] APPLICATIONS OF [I-131] M-IODOBENZYLGUANIDINE ([I-131]MIBG)
    BEIERWALTES, WH
    NUCLEAR MEDICINE AND BIOLOGY, 1987, 14 (03): : 183 - 189
12345